Jefferies Group LLC Mersana Therapeutics, Inc. Put Options Transaction History
Jefferies Group LLC
- $10.2 Billion
- Q3 2022
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MRSN
# of Institutions
71Shares Held
85.2MCall Options Held
34.3KPut Options Held
14K-
Nextech Invest Ag12.1MShares$95.3 Million3.22% of portfolio
-
Nextech Invest, Ltd. Zurich, V812.1MShares$95.3 Million0.68% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$68.4 Million0.78% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$66.2 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY5.67MShares$44.8 Million0.01% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $768M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...